Eledon Pharmaceuticals Inc. buy Guggenheim
Start price
18.11.25
/
50%
€1.34
Target price
18.11.26
€6.90
Performance (%)
94.03%
Price
02.04.26
€2.50
Summary
This prediction is currently active. With a performance of 94.03% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 18.11.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eledon Pharmaceuticals Inc. | 2.459% | 2.459% |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
Comments by Guggenheim for this prediction
In the thread Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for ELDN provided by MarketBeat
Stopped prediction by Guggenheim for Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.54
28.01.25
28.01.25
€8.63
28.01.26
28.01.26
-61.89%
29.01.26
29.01.26
